Free Trial
ETR:MOR

MorphoSys (MOR) Stock Price, News & Analysis

MorphoSys logo
€67.25 0.00 (0.00%)
As of 08/20/2024

About MorphoSys Stock (ETR:MOR)

Key Stats

Today's Range
€66.70
€67.30
50-Day Range
€67.25
€67.25
52-Week Range
€14.52
€69.75
Volume
5,144 shs
Average Volume
153,687 shs
Market Capitalization
€2.53 billion
P/E Ratio
N/A
Dividend Yield
1.26%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

MOR Stock News Headlines

Elon Leaves DOGE? Here’s What’s Next…
Early investors in Tesla saw 30,000% returns. SpaceX? Similar story. Now, Elon Musk is going all-in on something even bigger: artificial superintelligence. He’s calling it the next evolution of AI—and insiders are already calling it “AI 2.0.” The project is advancing quickly, and a key update could be announced as early as this summer. You can’t invest directly in Elon’s new tech—but there’s a backdoor way in.
Novartis raises sales guidance until 2028
See More Headlines

MOR Stock Analysis - Frequently Asked Questions

MorphoSys' stock was trading at €67.25 at the beginning of 2025. Since then, MOR shares have increased by 0.0% and is now trading at €67.25.

Based on aggregate information from My MarketBeat watchlists, some other companies that MorphoSys investors own include Novo Nordisk A/S (NVO), Bristol Myers Squibb (BMY), NVIDIA (NVDA), SolarEdge Technologies (SEDG), Gilead Sciences (GILD), AbbVie (ABBV) and Abbott Laboratories (ABT).

Industry, Sector and Symbol

Stock Exchange
ETR
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
ETR:MOR
CIK
N/A
Fax
N/A
Employees
730
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
(€12.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
322.58
P/E Growth
0.06
Net Income
-€460.81 million
Net Margins
-226.08%
Pretax Margin
N/A
Return on Equity
742.62%
Return on Assets
-13.84%

Debt

Debt-to-Equity Ratio
-96.49
Current Ratio
1.38
Quick Ratio
3.49

Sales & Book Value

Annual Sales
€203.82 million
Price / Sales
12.43
Cash Flow
€129.73 per share
Price / Cash Flow
0.52
Book Value
(€6.96) per share
Price / Book
-9.67

Miscellaneous

Outstanding Shares
37,662,715
Free Float
N/A
Market Cap
€2.53 billion
Optionable
Not Optionable
Beta
0.66
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ETR:MOR) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners